SHL Medical, a provider of advanced drug delivery systems such as autoinjectors, has entered into a non-exclusive co-marketing partnership agreement with Lifecore Biomedical, a CDMO that offers capabilities in the development, fill and finish of complex sterile injectable pharmaceuticals in syringes and vials.

Through this partnership, Lifecore becomes a member of SHL’s recently announced Alliance Management program, an initiative created to further SHL’s customer engagement with other key players within the drug delivery ecosystem.

SHL and Lifecore will exchange knowledge and experience in their respective fields to provide customers with guidance in CDMO services and best-in-class options for drug delivery device development.

SHL offers drug delivery device solutions for the development, manufacturing, and final assembly of its autoinjector products. The partnership with Lifecore will allow SHL to recommend a trusted CDMO with proficiency and robust quality systems in aseptic pharmaceutical manufacturing and primary container filling, creating a comprehensive support system across all stages of the autoinjector development and commercial lifecycle.

“As a true partner to pharma and biotech, we believe in providing full end-to-end solutions that enhance patients’ quality of life and enable patients’ independence,” said Kimberlee Steele, managing director of SHL Pharma, SHL Medical’s final assembly, labeling, and packaging business unit in Florida. “We are excited to partner with Lifecore to provide high-quality CDMO services matching SHL’s own high-touch approach to servicing our customers.”

Darren Hieber, senior vice president of corporate development and partnerships for Lifecore said, “We are continuously adapting to keep pace with the evolution of healthcare treatments and technologies and our deep expertise in the fill/finish of syringes and vials is a perfect match for SHL’s products. Our relationship with SHL will expand the breadth of our offerings to our CDMO customers, enabling them to deliver the benefits and convenience of innovative drug delivery systems to their patients worldwide. We are excited to be aligned with an industry leader, who has created a business focused on patient-centric solutions through their unique, convenient, high-quality product portfolio.”